Effects of Dexmedetomidine on Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is a selective α2 adrenergic agonist that can be considered analgesics,
anxiolytic,and anti-stress effect . This randomized, double-blind placebo-controlled trial of
intraoperative dexmedetomidine for improvement of quality of recovery and analgesia from
surgery. Patients scheduled to undergo video-assisted thoracoscopic surgery (VATS) will be
enrolled. Patients will be recruited before the date of their surgery and will complete the
Quality of Recovery-40 (QoR-40) questionnaire before their surgery and at 24 and 48 hours
post op. They will also complete clinically significant pains score and oxygenation from the
postanesthetic recovery unit (PACU).